Dr. Michael Itidiare, DO

Dr. Itidiare practices at AtlantiCare Regional Medical Center, Mainland Campus - Mammography in Pomona, New Jersey.

Dr. Itidiare's NPI, 1316388556, was assigned on July 16, 2013. Dr. Itidiare holds New Jersey license 25MB10130600.

Dr. Itidiare's primary practice is AtlantiCare Regional Medical Center, Mainland Campus - Mammography, at 65 Jimmie Leeds Rd., Pomona, NJ 08240. The practice phone is (609) 383-2800.

Dr. Itidiare's primary practice is AtlantiCare Regional Medical Center, Mainland Campus - Mammography in Pomona, New Jersey. Dr. Itidiare is also affiliated with MedStar Georgetown University Hospital. The medical group on file is AtlantiCare Physician Group. Dmand AI also links Dr. Itidiare to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Itidiare practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Itidiare's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Itidiare is licensed in New Jersey.

CMS data shows 205 Medicare services from Dr. Itidiare across 3 procedure codes in 2024, for 97 Medicare patients. Medicare paid $20,428 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Dr. Itidiare in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Itidiare's median patient age at 63, with 53% women.

In 2024, Dr. Itidiare wrote 46 Medicare Part D claims for 39 patients. 78% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $1,494 in total drug cost. In 2023, CMS named 70 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Itidiare for performance year 2024, reported through an alternative payment model (APM). Dr. Itidiare accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 86 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Itidiare, more than 73% of the clinicians it reports for that procedure.

CMS Open Payments shows 9 general payments to Dr. Itidiare from 3 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $444.